While there are highly effective treatments for the hepatitis C virus (HCV), only 1 in 5 Medicaid enrollees diagnosed with HCV started treatment, according to a retrospective study led by researchers at Weill Cornell Medicine and Cornell University’s Ithaca campus.
Leveraging Technology to Improve Pharmaceutical Oversight and Patient Safety
In a time when healthcare is always changing, the pharmaceutical sector is under more pressure to ensure patient safety while maintaining compliance with stringent regulatory
October 11, 2024